Regenerative potential of retinal Muller glial cells
视网膜米勒胶质细胞的再生潜力
基本信息
- 批准号:7761723
- 负责人:
- 金额:$ 5.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseBehaviorBiological ModelsBlindnessBlood VesselsCell CycleCellsCicatrixCognitiveComplexDataDiseaseEnvironmentEventExhibitsFigs - dietaryGenerationsGeneticGliosisGoalsHeartHumanImageIntermediate FilamentsLabelLifeLightMammalsMapsMitosisMitoticMolecularMusMutant Strains MiceNatural regenerationNerve DegenerationNeurogliaNeuronsOuter Limiting MembraneParkinson DiseasePopulationRegenerative MedicineResearchResearch ProposalsRetinaRetinalSensorySystemTamoxifenTestingTherapeuticTimeTransplantationVimentincell behaviorin vivomotor disordernervous system disorderrecombinaseregenerativerepairedresearch studyresponseretinal damageretinal neuron
项目摘要
DESCRIPTION (provided by applicant): The objective of this research proposal is to determine the potential of the mammalian retina for repair via endogenous mechanisms. In response to retinal damage, Muller glial (MG) cells of several vertebrate model systems have been shown to give rise to new retinal neurons. However, in mammals, there is a paucity of data directly testing the regenerative capacity of MG cells in vivo. Our central hypothesis is that, in response to retinal damage, mature mouse MG cells possess the ability to re-enter the cell cycle and trans-differentiate into retinal neurons. The overall goal of this proposal is to test this hypothesis by performing genetic, Cre-loxP fate mapping experiments and time lapse imaging. Aim 1. Determine the capacity of mouse Muller glial cells to give rise to mature retinal neurons within specific environmental contexts. We will test the hypothesis that retinal Muller glial (MG) cells have the ability to regenerate retinal neurons by chemically inducing neuronal degeneration and performing in vivo Cre-loxP fate-mapping experiments. We will also test the hypothesis that MG cell regenerative potential is significantly hindered as a consequence of a non-permissive retinal environment due to glial scarring. Here, we will perform the same fate-mapping experiment, but within the genetic background of Vimentin-/-; Gfap-/- mutant mice known to exhibit a retinal environment substantially more supportive of neuronal transplantation. Aim 2. Elucidate the cellular mechanisms of the Muller glial response to retinal damage and subsequent trans-differentiation events. We hypothesize that, in response to damage, a discrete subset of MG cells re-enter the cell cycle and translocate apically toward the outer limiting membrane of the retina where they undergo mitosis before translocating to the appropriate lamina as differentiating neurons. To test this hypothesis, we will perform live imaging of damage-induced retinal explants in which MG cells are fluorescently labeled. RELEVANCE Neuronal degeneration lies at the heart of a spectrum of debilitating human cognitive and motor diseases including Alzheimer's and Parkinson's disease as well as sensory diseases such as blindness. By characterizing cell populations within the retina, which have the ability to generate new neurons, therapeutic approaches could be employed to harness the ability of these cells to cure human neurological diseases.
描述(由申请人提供):本研究计划的目的是确定通过内源性机制修复哺乳动物视网膜的潜力。在对视网膜损伤的反应中,Muller胶质细胞(MG)在几种脊椎动物模型系统中已经被证明产生新的视网膜神经元。然而,在哺乳动物中,缺乏直接测试MG细胞在体内再生能力的数据。我们的中心假设是,在视网膜损伤的反应中,成熟的小鼠MG细胞具有重新进入细胞周期并转分化为视网膜神经元的能力。本提案的总体目标是通过进行遗传,Cre-loxP命运映射实验和延时成像来验证这一假设。目的1。确定小鼠Muller胶质细胞在特定环境下产生成熟视网膜神经元的能力。我们将通过化学诱导神经元变性和体内Cre-loxP命运定位实验来验证视网膜Muller胶质(MG)细胞具有再生视网膜神经元能力的假设。我们还将验证一个假设,即由于神经胶质瘢痕形成的不允许的视网膜环境,MG细胞的再生潜力受到显著阻碍。在这里,我们将进行相同的命运定位实验,但在遗传背景Vimentin-/-;已知Gfap-/-突变小鼠表现出更支持神经元移植的视网膜环境。目标2。阐明Muller胶质细胞对视网膜损伤和随后的反分化事件反应的细胞机制。我们假设,作为对损伤的反应,MG细胞的一个离散子集重新进入细胞周期,并向视网膜的外限制膜顶端移位,在那里它们进行有丝分裂,然后作为分化的神经元转移到适当的层。为了验证这一假设,我们将对损伤诱导的视网膜外植体进行实时成像,其中MG细胞被荧光标记。神经元变性是一系列使人衰弱的人类认知和运动疾病的核心,包括阿尔茨海默病和帕金森病,以及失明等感觉疾病。通过表征视网膜内具有产生新神经元能力的细胞群,可以采用治疗方法来利用这些细胞的能力来治愈人类神经系统疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ross Anthony Poche其他文献
Ross Anthony Poche的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ross Anthony Poche', 18)}}的其他基金
Ronin (Thap11) in Neural Crest Cell Development
Ronin (Thap11) 在神经嵴细胞发育中的作用
- 批准号:
9817157 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Ronin (Thap11) in Neural Crest Cell Development
Ronin (Thap11) 在神经嵴细胞发育中的作用
- 批准号:
9978042 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Ronin (Thap11) in Neural Crest Cell Development
Ronin (Thap11) 在神经嵴细胞发育中的作用
- 批准号:
10392396 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Hippo Pathway Regulation of Müller Glial Cell-mediated Retinal Regeneration
Müller 胶质细胞介导的视网膜再生的 Hippo 通路调节
- 批准号:
10202615 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Hippo Pathway Regulation of Müller Glial Cell-mediated Retinal Regeneration
Müller 胶质细胞介导的视网膜再生的 Hippo 通路调节
- 批准号:
10438586 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Ronin (Thap11) in Neural Crest Cell Development
Ronin (Thap11) 在神经嵴细胞发育中的作用
- 批准号:
10614379 - 财政年份:2019
- 资助金额:
$ 5.05万 - 项目类别:
Transcriptional regulation of retinal mitochondrial function and cell cycle
视网膜线粒体功能和细胞周期的转录调控
- 批准号:
9439898 - 财政年份:2014
- 资助金额:
$ 5.05万 - 项目类别:
Transcriptional regulation of retinal mitochondrial function and cell cycle
视网膜线粒体功能和细胞周期的转录调控
- 批准号:
8797939 - 财政年份:2014
- 资助金额:
$ 5.05万 - 项目类别:
Regenerative potential of retinal Muller glial cells
视网膜米勒胶质细胞的再生潜力
- 批准号:
7614702 - 财政年份:2009
- 资助金额:
$ 5.05万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 5.05万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别: